Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


10.09.2018

1 Arch Virol
1 BMJ
1 Clin Infect Dis
2 J Infect Dis
3 J Virol
1 Lancet Infect Dis
1 Nat Med
5 PLoS One
1 Proc Natl Acad Sci U S A
13 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. LIU J, Xue L, Hu S, Cheng H, et al
    Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Arch Virol. 2018 Sep 5. pii: 10.1007/s00705-018-4016.
    PubMed     Text format     Abstract available


    BMJ

  2. HAWKES N
    Cochrane editors hit back at criticisms of HPV vaccine review.
    BMJ. 2018;362:k3834.
    PubMed     Text format    


    Clin Infect Dis

  3. POMAT WS, van den Biggelaar AHJ, Wana S, Greenhill AR, et al
    Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.
    Clin Infect Dis. 2018 Sep 3. pii: 5089945. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. MARSHALL HS, Clarke M, Heath C, Quinn H, et al
    Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program.
    J Infect Dis. 2018 Sep 3. pii: 5089719. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. HARRIS JB
    Cholera: Immunity and Prospects in Vaccine Development.
    J Infect Dis. 2018 Sep 1. pii: 5089248. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  6. DARRICARRERE N, Pougatcheva S, Duan X, Rudicell RS, et al
    Development of a Pan-H1 Influenza Vaccine.
    J Virol. 2018 Sep 5. pii: JVI.01349-18. doi: 10.1128/JVI.01349.
    PubMed     Text format     Abstract available

  7. TSAI WY, Chen HL, Tsai JJ, Dejnirattisai W, et al
    Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine.
    J Virol. 2018 Sep 5. pii: JVI.00556-18. doi: 10.1128/JVI.00556.
    PubMed     Text format     Abstract available

  8. ABENTE EJ, Rajao DS, Santos J, Kaplan BS, et al
    Comparison of adjuvanted-whole inactivated virus and live-attenuated virus vaccines against challenge with contemporary, antigenically distinct swine H3N2 influenza A viruses.
    J Virol. 2018 Sep 5. pii: JVI.01323-18. doi: 10.1128/JVI.01323.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  9. ANDREWS JR, Baker S, Marks F, Alsan M, et al
    Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance.
    Lancet Infect Dis. 2018 Aug 28. pii: S1473-3099(18)30350.
    PubMed     Text format     Abstract available


    Nat Med

  10. ACKERMAN ME, Das J, Pittala S, Broge T, et al
    Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV.
    Nat Med. 2018 Sep 3. pii: 10.1038/s41591-018-0161.
    PubMed     Text format     Abstract available


    PLoS One

  11. MATTHIJSSE SM, Naber SK, Hontelez JAC, Bakker R, et al
    The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
    PLoS One. 2018;13:e0202924.
    PubMed     Text format     Abstract available

  12. HEGERLE N, Choi M, Sinclair J, Amin MN, et al
    Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    PLoS One. 2018;13:e0203143.
    PubMed     Text format     Abstract available

  13. BOZIO CH, Abdul-Karim A, Abenyeri J, Abubakari B, et al
    Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2018;13:e0203205.
    PubMed     Text format     Abstract available

  14. VOYSEY M, Sadarangani M, Pollard AJ, Fanshawe TR, et al
    Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias.
    PLoS One. 2018;13:e0202517.
    PubMed     Text format     Abstract available

  15. SANAPALA S, Mosca L, Wang S, Curtiss R, et al
    Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.
    PLoS One. 2018;13:e0203526.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. PARKS RJ, Gussoni E
    Building immune tolerance through DNA vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 6. pii: 1813461115.
    PubMed     Text format    


    Vaccine

  17. WESTFALL J, Yates JL, Van Slyke G, Ehrbar D, et al
    Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31188.
    PubMed     Text format     Abstract available

  18. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
    The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
    PubMed     Text format     Abstract available

  19. NZOLO D, Engo Biongo A, Kuemmerle A, Lusakibanza M, et al
    Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31181.
    PubMed     Text format     Abstract available

  20. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
    The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
    PubMed     Text format     Abstract available

  21. ROOZBEHANI M, Falak R, Mohammadi M, Hemphill A, et al
    Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31208.
    PubMed     Text format     Abstract available

  22. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
    Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
    PubMed     Text format     Abstract available

  23. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
    Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
    Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
    PubMed     Text format     Abstract available

  24. ORENSTEIN WA, Hinman A, Nkowane B, Olive JM, et al
    Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Vaccine. 2018;36 Suppl 1:A1-A34.
    PubMed     Text format     Abstract available

  25. ORENSTEIN WA, Cairns L, Hinman A, Nkowane B, et al
    Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Vaccine. 2018;36 Suppl 1:A35-A42.
    PubMed     Text format     Abstract available

  26. NORHEIM G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, et al
    Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
    Vaccine. 2018;36:1297-1303.
    PubMed     Text format     Abstract available

  27. GUERRA FM, Crowcroft NS, Friedman L, Deeks SL, et al
    Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Vaccine. 2018;36:1248-1255.
    PubMed     Text format     Abstract available

  28. BRUXELLE JF, Tsapis N, Hoys S, Collignon A, et al
    Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31122.
    PubMed     Text format     Abstract available

  29. MOHANTY S, Leader AE, Gibeau E, Johnson C, et al
    Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31189.
    PubMed     Text format     Abstract available


    Virus Res

  30. LI Y, Chen S, Fang J, Zhu Y, et al
    Construction of an attenuated Tian Tan vaccinia virus strain by deletion of TA35R and TJ2R genes.
    Virus Res. 2018;256:192-200.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: